BGLC vs CMS · rev $9.5M vs P/E 20, $22.42B cap
BioNexus Gene Lab Corp Common stock (BGLC) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
CMS does not have a complete income-statement cache yet.
BGLC currently screens at market cap $6.1M. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the BGLC and CMS stock pages for the full models.
Not investment advice.